149 related articles for article (PubMed ID: 1656576)
1. Surveillance for clinical stage I nonseminomatous testis carcinoma: rationale and results.
Stephenson RA
Urol Int; 1991; 46(3):290-3. PubMed ID: 1656576
[TBL] [Abstract][Full Text] [Related]
2. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Divrik RT; Akdoğan B; Ozen H; Zorlu F
J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors.
Li X; Guo S; Wu Z; Dong P; Li Y; Zhang Z; Yao K; Han H; Qin Z; Zhou F; Liu Z
World J Urol; 2015 Sep; 33(9):1351-7. PubMed ID: 25471669
[TBL] [Abstract][Full Text] [Related]
5. Surveillance in patients with stage I nonseminomatous testicular tumors.
Litwin MS; Richie JP
Surg Annu; 1994; 26():89-99. PubMed ID: 8303525
[No Abstract] [Full Text] [Related]
6. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
Powles T
Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
[TBL] [Abstract][Full Text] [Related]
7. Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance.
Wishnow KI; Johnson DE; Swanson DA; Tenney DM; Babaian RJ; Dunphy CH; Ayala AG; Ro JY; von Eschenbach AC
Urology; 1989 Dec; 34(6):339-43. PubMed ID: 2480680
[TBL] [Abstract][Full Text] [Related]
8. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.
Sturgeon JF; Moore MJ; Kakiashvili DM; Duran I; Anson-Cartwright LC; Berthold DR; Warde PR; Gospodarowicz MK; Alison RE; Liu J; Ma C; Pond GR; Jewett MA
Eur Urol; 2011 Apr; 59(4):556-62. PubMed ID: 21190791
[TBL] [Abstract][Full Text] [Related]
9. Observation after orchiectomy in clinical stage I nonseminomatous germ cell tumor of testis. Mayo Clinic experience.
Patel SR; Richardson RL; Kvols L; Zincke H
Am J Clin Oncol; 1990 Oct; 13(5):379-81. PubMed ID: 2171316
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
[TBL] [Abstract][Full Text] [Related]
11. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
12. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson DA
Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
[No Abstract] [Full Text] [Related]
13. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
14. Is scrotal violation per se a risk factor for local relapse and metastases in stage I nonseminomatous testicular cancer?
Aki FT; Bilen CY; Tekin MI; Ozen H
Urology; 2000 Sep; 56(3):459-62. PubMed ID: 10962315
[TBL] [Abstract][Full Text] [Related]
15. Orchiectomy only for clinical stage I nonseminomatous germ cell testis tumors: comparison with pathologic stage I disease.
Freiha F; Torti F
Urology; 1989 Dec; 34(6):347-8. PubMed ID: 2556828
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of patients after retroperitoneal lymphadenectomy for clinical stage I nonseminomatous germ cell tumour of the testis.
Hornák M; Zvara V; Ondrus D; Bárdos A
Czech Med; 1987; 10(2):109-16. PubMed ID: 2820669
[TBL] [Abstract][Full Text] [Related]
17. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
[TBL] [Abstract][Full Text] [Related]
18. Clinical stage I testis cancer: long-term outcome of patients on surveillance.
Sogani PC; Perrotti M; Herr HW; Fair WR; Thaler HT; Bosl G
J Urol; 1998 Mar; 159(3):855-8. PubMed ID: 9474168
[TBL] [Abstract][Full Text] [Related]
19. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
20. Surveillance results of patients with stage I nonseminomatous germ cell testicular cancer.
Keskin S; Ekenel M; Başaran M; Bavbek S
Onkologie; 2011; 34(4):173-6. PubMed ID: 21447974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]